To access this element change to forms mode OFF
Grant Award View - GA283743
Nanoparticle manufacturing and its application in brain cancer...
GA ID:
GA283743
Agency:
Department of Industry, Science and Resources
Approval Date:
5-Jan-2023
Publish Date:
10-Feb-2023
Category:
Industry Innovation
Grant Term:
9-Feb-2023 to 9-Jun-2026
Value (AUD):
$3,300,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 22/23 Investing in science, technology and commercialisation
Grant Program:
Cooperative Research Centres Programme
Grant Activity:
Nanoparticle manufacturing and its application in brain cancer radiotherapy
Purpose:
Grant funding will support Ferronova and the project partners to address issues relating to image guided cancer surgery and therapy. Nanotechnology has been widely researched in oncology, but clinical translation has been limited by complex manufacturing and limited effectiveness in vivo. The CRC-P will develop commercial scale manufacturing of Ferronovas FerroTrace SPION platform. The testbed will be FerroTrace-FAPi, a preclinically validated theranostic product for image guided radiotherapy and proton therapy. The safety and effectiveness of FerroTrace-FAPi will be evaluated in a Phase 1b clinical trial in glioblastoma.
GO ID:
GO Title:
Cooperative Research Centres Projects - Round 13
Internal Reference ID:
CRCPXIII000144
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
FERRONOVA PTY LTD
Recipient ABN:
89 612 664 347
Grant Recipient Location
Suburb:
SALISBURY SOUTH
Town/City:
SALISBURY SOUTH
Postcode:
5109
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
5095
Country:
AUSTRALIA